Total Payments
$2,751
2024 Payments
$869.65
Companies
24
Transactions
174
Medicare Patients
8,351
Medicare Billing
$307,169
Payment Breakdown by Category
Food & Beverage$2,751 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,751 | 174 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $541.77 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $492.22 | 21 | $0 (2024) |
| Novo Nordisk Inc | $408.97 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $390.36 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $220.57 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $175.07 | 8 | $0 (2024) |
| Lilly USA, LLC | $112.37 | 8 | $0 (2022) |
| Medtronic, Inc. | $56.49 | 3 | $0 (2024) |
| Amgen Inc. | $46.04 | 3 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $37.19 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $869.65 | 48 | ABBVIE INC. ($191.37) |
| 2023 | $740.32 | 55 | ABBVIE INC. ($177.07) |
| 2022 | $713.85 | 43 | ABBVIE INC. ($173.33) |
| 2021 | $426.76 | 28 | AstraZeneca Pharmaceuticals LP ($151.38) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: VTE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Obesity | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardio-renal | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: Obesity | ||||||
| 05/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 1,913 | 3,277 | $164,012 | $69,970 |
| 2022 | 46 | 2,200 | 3,551 | $190,521 | $81,096 |
| 2021 | 40 | 2,286 | 3,618 | $195,970 | $90,828 |
| 2020 | 34 | 1,952 | 2,868 | $158,500 | $65,273 |
Total Patients
8,351
Total Services
13,314
Medicare Billing
$307,169
Procedure Codes
161
All Medicare Procedures & Services
161 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 576 | $74,880 | $38,322 | 51.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 109 | 122 | $7,930 | $5,573 | 70.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $4,875 | $3,822 | 78.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 59 | 78 | $7,800 | $2,192 | 28.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 110 | 204 | $2,448 | $1,656 | 67.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 110 | 184 | $6,992 | $1,345 | 19.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,296 | $1,270 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 23 | $2,070 | $1,149 | 55.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 95 | 147 | $3,675 | $1,076 | 29.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 50 | 69 | $3,726 | $1,010 | 27.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 52 | 61 | $2,440 | $934.69 | 38.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 42 | 55 | $3,135 | $894.39 | 28.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 53 | 187 | $2,805 | $866.59 | 30.9% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 15 | 22 | $1,650 | $846.34 | 51.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 55 | 63 | $3,087 | $794.81 | 25.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 60 | 86 | $3,440 | $696.36 | 20.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $736.00 | $645.15 | 87.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 47 | 57 | $2,850 | $572.92 | 20.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 111 | 183 | $2,743 | $550.36 | 20.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 39 | 39 | $702.00 | $542.10 | 77.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 12 | 23 | $1,702 | $537.30 | 31.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 15 | $2,890 | $528.18 | 18.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 56 | $2,016 | $526.00 | 26.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 21 | 41 | $1,580 | $469.30 | 29.7% |
| 83735 | Magnesium level | Office | 2023 | 48 | 65 | $1,300 | $422.51 | 32.5% |
About Robert Greenlee, FNP
Robert Greenlee, FNP is a Family healthcare provider based in Kosciusko, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1710401575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Greenlee, FNP has received a total of $2,751 in payments from pharmaceutical and medical device companies, with $869.65 received in 2024. These payments were reported across 174 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,751).
As a Medicare-enrolled provider, Greenlee has provided services to 8,351 Medicare beneficiaries, totaling 13,314 services with total Medicare billing of $307,169. Data is available for 4 years (2020–2023), covering 161 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Kosciusko, MS
- Active Since 08/02/2017
- Last Updated 08/02/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1710401575
Products in Payments
- BREZTRI (Drug) $262.20
- LEQVIO (Drug) $260.50
- FARXIGA (Drug) $211.68
- Ozempic (Drug) $183.61
- Rybelsus (Drug) $175.74
- VRAYLAR (Drug) $167.26
- UBRELVY (Drug) $158.86
- QULIPTA (Drug) $131.61
- ENTRESTO (Drug) $129.86
- OFEV (Drug) $113.86
- TRELEGY ELLIPTA (Drug) $110.81
- AREXVY (Drug) $95.85
- TRULICITY (Drug) $95.77
- Otezla (Drug) $46.04
- INTELLIS ADAPTIVESTIM (Device) $41.92
- VOQUEZNA (Drug) $37.19
- CREON (Drug) $34.74
- XIFAXAN (Drug) $32.76
- RYBELSUS (Drug) $27.81
- Xofluza (Drug) $26.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Kosciusko
Mr. Timothy South, Fnp, FNP
Family — Payments: $4,999
Family $4,999
Meagan Carpenter, Fnp, FNP
Family — Payments: $1,641
Family $1,641
Candice Parish, Fnp-C, FNP-C
Family — Payments: $850.03
Family $850.03
Kayla Ferguson, Fnp-C, FNP-C
Family — Payments: $606.75
Family $606.75
Mrs. Linda Cockroft, Fnp, FNP
Family — Payments: $217.54
Family $217.54
Allison Langford, Fnp, FNP
Family — Payments: $186.26
Family $186.26